"SpeciCare (B4CC, Inc.) focuses on arming cancer patients with new hope, innovative solutions, time and quality of life through the use of Live Tissue Science. SpeciCare’s live tumor tissue banking process enables access to previously inaccessible extensive testing, clinical trials and cutting-edge therapies to improve patient outcomes and quality of life."

During the past decade, Specicare conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Specicare" #1 collaborator was "Georgia Institute of Technology" with 1 trials as a collaborator, "Netnoids" with 1 trials as a collaborator, "Northeast Georgia Hospital System" with 1 trials as a collaborator, "Predictive Oncology" with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Specicare" are "Adenocarcinoma Lung" (1 trials), "Adrenal Cancer" (1 trials), "Breast Cancer" (1 trials), "Bronchoalveolar Cell Lung Cancer" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Specicare" in a lesser frequency.

Most popular intervention types in "Specicare" are "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Freenome Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specicare" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specicare". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Specicare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specicare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".